New hypertension drug candidate BCD101 enters first human safety tests
Knowledge-focused
Recruiting now
This early-stage study tests the safety and tolerability of a new drug called BCD101 in 56 healthy adults. Participants receive either the drug or a placebo, and researchers monitor for side effects and measure how the drug moves through the body. The goal is not to treat high bl…
Phase: PHASE1 • Sponsor: Bichedam Co., Ltd. • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC